The first experiment compared the ability of either BM CD11b+ cells from CCR2+ donors to support tumor development in CCR2−/− mice (Fig. 2), and the other experiment compared the ability of purified CX3CR1 (GFP+) cells from CCR2+ mice to do so (Fig. 3). The gene discussed is CX3CR1; the disease is neoplasm.